Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017 IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes November 9, 2017 Pfizer to Cut 300 Jobs as It Ends Alzheimer's, Parkinson's Quest January 7, 2018
Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years September 14, 2017
